Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001711459-17-000001
Filing Date
2017-07-10
Accepted
2017-07-10 17:10:34
Documents
1
Effectiveness Date
2017-07-10
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 7084
  Complete submission text file 0001711459-17-000001.txt   8105
Mailing Address 479 JESSIE STREET SAN FRANCISCO CA 94103
Business Address 479 JESSIE STREET SAN FRANCISCO CA 94103 (415) 742-1283
Prellis Biologics, Inc (Filer) CIK: 0001711459 (see all company filings)

EIN.: 815455517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-290340 | Film No.: 17958457